Prognostic significance of serum microRNA-210 levels in nonsmall-cell lung cancer

Journal of International Medical Research

Volumn 41, Issue 5, 2013, Pages 1437-1444

  Li, Zhi Hong ^a   Zhang, Hong ^a   Yang, Zhi Guang ^a   Wen, Guo Qiang ^a   Cui, You Bing ^a   Shao, Guo Guang ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

microRNA; microRNA 210; Nonsmall cell lung cancer; prognostic significance; serum

Indexed keywords

CISPLATIN; MICRORNA 210;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DRUG RESPONSE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

MICRORNA; MICRORNA-210; NONSMALL CELL LUNG CANCER; PROGNOSTIC SIGNIFICANCE; SERUM;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CISPLATIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84887264940     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/0300060513497560     Document Type: Article

References (28)

1. Jemal A,Bray F,Center MM, et al.Global cancer statistics.CA Cancer J Clin. 2011;61:69-90.
2. Miller YE.Pathogenesis of lung cancer: 100 year report.Am J Respir Cell Mol Biol. 2005;33:216-223.
3. Esquela-Kerscher A,Slack FJ.Oncomirs- microRNAs with a role in cancer.Nat Rev Cancer. 2006;6:259-269.
4. Chen X,Ba Y,Ma L, et al.Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases.Cell Res. 2008;18:997-1006.
5. Cheng Y,Tan N,Yang J, et al.A translational study of circulating cell-free microRNA-1 in acute myocardial infarction.Clin Sci (Lond). 2010;119:87-95.
6. Lodes MJ,Caraballo M,Suciu D, et al.Detection of cancer with serum miRNAs on an oligonucleotide microarray.PLoS One. 2009;4:e6229-e6229.
7. Gilad S,Meiri E,Yogev Y, et al.Serum microRNAs are promising novel biomarkers.PLoS One. 2008;3:e3148-e3148.
8. Hu Z,Chen X,Zhao Y, et al.Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.J Clin Oncol. 2010;28:1721-1726.
9. Mitchell PS,Parkin RK,Kroh EM, et al.Circulating microRNAs as stable blood-based markers for cancer detection.Proc Natl Acad Sci U S A. 2008;105:10513-10518.
10. Shen J,Todd NW,Zhang H, et al.Plasma microRNAs as potential biomarkers for non-small-cell lung cancer.Lab Invest. 2011;91:579-587.
11. Zheng D,Haddadin S,Wang Y, et al.Plasma microRNAs as novel biomarkers for early detection of lung cancer.Int J Clin Exp Pathol. 2011;4:575-586.
12. Zhao A,Li G,Péoc'h M, et al.Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma.Exp Mol Pathol. 2013;94:115-120.
13. Ho AS,Huang X,Cao H, et al.Circulating miR-210 as a novel hypoxia marker in pancreatic cancer.Transl Oncol. 2010;3:109-113.
14. Grosso S,Doyen J,Parks SK, et al.miR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines.Cell Death Dis. 2013;4:e544-e544.
15. Puisségur MP,Mazure NM,Bertero T, et al.miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity.Cell Death Differ. 2011;18:465-478.
16. Tio TL.The TNM staging system.Gastrointest Endosc. 1996;43:S19-S24.
17. Miller AB,Hoogstraten B,Staquet M, et al.Reporting results of cancer treatment.Cancer. 1981;47:207-214.
18. Wong TS,Liu XB,Wong BY, et al.Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue.Clin Cancer Res. 2008;14:2588-2592.
19. Ng EK,Chong WW,Jin H, et al.Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.Gut. 2009;58:1375-1381.
20. Heneghan HM,Miller N,Lowery AJ, et al.Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.Ann Surg. 2010;251:499-505.
21. Van Schil PE,Hendriks JM,Hertoghs M, et al.Current surgical treatment of non-small-cell lung cancer.Expert Rev Anticancer Ther. 2011;11:1577-1585.
22. Kuehbacher A,Urbich C,Dimmeler S.Targeting microRNA expression to regulate angiogenesis.Trends Pharmacol Sci. 2008;29:12-15.
23. Davidson-Moncada J,Papavasiliou FN,Tam W.MicroRNAs of the immune system: roles in inflammation and cancer.Ann N Y Acad Sci. 2010;1183:183-194.
24. Camps C,Buffa FM,Colella S, et al.hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer.Clin Cancer Res. 2008;14:1340-1348.
25. Neal CS,Michael MZ,Rawlings LH, et al.The VHL-dependent regulation of microRNAs in renal cancer.BMC Med. 2010;8:64-64.
26. Cohen HT,McGovern FJ.Renal-cell carcinoma.N Engl J Med. 2005;353:2477-2490.
27. Huang Z,Huang D,Ni S, et al.Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.Int J Cancer. 2010;127:118-126.
28. Hong F,Li Y,Xu Y, et al.Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.J Int Med Res. 2013;41:64-71.